Recommended a Final Dividend - 67.5% i.e. Rs. 1.35/- per Equity Share on the face value of Rs. 2 each for the Financial Year 2025-26, Subject to the approval of the Shareholders at the ....
ADVENZYMES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Advanced Enzyme Technologies Ltd's Board has recommended a final dividend of Rs. 1.35 per equity share (67.5% on face value of Rs. 2) for FY 2025-26, subject to shareholder approval at the 37th AGM. The company reported strong growth with consolidated revenue from operations of Rs. 7,457.57 million (up 17% YoY) and profit after tax of Rs. 1,736.08 million (up 29.6% YoY). Basic EPS improved to Rs. 15.08 from Rs. 11.72. The Board deferred declaring an interim dividend, stating it wants to preserve capital for potential strategic avenues. The company also allotted 49,350 equity shares under its ESOP 2022 scheme, appointed a new independent director, and reappointed its statutory auditors.
The dividend signals confidence in the company's financial health with robust profit growth. However, deferring an interim dividend and preserving capital suggests the company may be evaluating larger strategic actions that could benefit long-term shareholders. The stock may see positive reaction given the earnings growth and dividend declaration.